Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group
Por:
Arrieta, O, Cardona, AF, Lara-Mejia, L, Heredia, D, Barron, F, Zatarain-Barron, ZL, Lozano, F, de Lima, VC, Maldonado, F, Corona-Cruz, F, Ramos, M, Cabrera, L, Martin, C, Corrales, L, Cuello, M, Arroyo-Hernandez, M, Aman, E, Bacon, L, Baez, R, Benitez, S, Botero, A, Burotto, M, Caglevic, C, Ferraris, G, Freitas, H, Kaen, DL, Lamot, S, Lyons, G, Mas, L, Mata, A, Mathias, C, Munoz, A, Patane, AK, Oblitas, G, Pino, L, Raez, LE, Remon, J, Rojas, L, Rolfo, C, Ruiz-Patino, A, Samtani, S, Viola, L, Viteri, S and Rosell, R
Publicada:
1 sep 2020
Ahead of Print:
20 jun 2020
Resumen:
The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As such, lung cancer patients must be prioritized in terms of prevention, detection and treatment. On May 7th, 45 experts in thoracic cancers from 11 different countries were invited to participate. A core panel of experts regarding thoracic oncology care amidst the pandemic gathered virtually, and a total of 60 initial recommendations were drafted based on available evidence, 2 questions were deleted due to conflicting evidence. By May 16th, 44 experts had agreed to participate, and voted on each of the 58 recommendation using a Delphi panel on a live voting event. Consensus was reached regarding the recommendations (> 66 % strongly agree/agree) for 56 questions. Strong consensus (> 80 % strongly agree/agree) was reached for 44 questions. Patients with lung cancer represent a particularly vulnerable population during this time. Special care must be taken to maintain treatment while avoiding exposure.
Filiaciones:
Arrieta, O:
Inst Natl Cancerol, Mexico City, DF, Mexico
Cardona, AF:
Thorac Oncol Clin, Clin Country, Bogota, Colombia
Fdn Clin & Appl Canc Res, Bogota, Colombia
Lara-Mejia, L:
Inst Natl Cancerol, Mexico City, DF, Mexico
Heredia, D:
Inst Natl Cancerol, Mexico City, DF, Mexico
Barron, F:
Inst Natl Cancerol, Mexico City, DF, Mexico
Zatarain-Barron, ZL:
Inst Natl Cancerol, Mexico City, DF, Mexico
Lozano, F:
Inst Natl Cancerol, Mexico City, DF, Mexico
de Lima, VC:
A C Camargo Canc Ctr, Dept Oncol Clin, Sao Paulo, Brazil
Maldonado, F:
Inst Natl Cancerol, Mexico City, DF, Mexico
Corona-Cruz, F:
Inst Natl Cancerol, Mexico City, DF, Mexico
Ramos, M:
Inst Natl Cancerol, Mexico City, DF, Mexico
Cabrera, L:
Inst Natl Cancerol, Mexico City, DF, Mexico
Martin, C:
Alexander Fleming Inst, Thorac Oncol Unk, Buenos Aires, DF, Argentina
Hosp Maria Ferrer, Buenos Aires, DF, Argentina
Corrales, L:
Hosp San Juan Dios, Oncol Dept, San Jose Costa Rica, Costa Rica
Ctr Invest & Manejo Canc CIMCA, Oncol Med, San Jose, Costa Rica
Cuello, M:
Univ Republ UDELAR, Hosp Clin, Dept Oncol, Montevideo, Uruguay
Arroyo-Hernandez, M:
Inst Natl Cancerol, Mexico City, DF, Mexico
Aman, E:
Swiss Med Grp, Clin Oncol Unk, Buenos Aires, DF, Argentina
Bacon, L:
Hosp Vivian Pallas, Ctr Oncol, Managua, Nicaragua
Baez, R:
Natl Inst Resp Dis, Mexico City, DF, Mexico
Benitez, S:
Assoc Argentina Med Resp, Coordinador Secc Oncol, Buenos Aires, DF, Argentina
Botero, A:
Hosp La Catolica Goicoechea, San Jose, Costa Rica
Burotto, M:
Clin Univ Andes, Ctr Estudios Clin Bradford Hill, Santiago, Chile
Caglevic, C:
Fdn Arturo Lopez Perez, Dept Invest Canc, Santiago, Chile
Ferraris, G:
Ctr Med Dean Funes, Radioterapia Oncol, Cordoba, Argentina
Freitas, H:
A C Camargo Canc Ctr, Dept Oncol Clin, Sao Paulo, Brazil
Kaen, DL:
Ctr Oncol Riojano Integral, La Rioja, Argentina
Lamot, S:
Inst Oncohematol Patagonia, CONCIENCIA, Rio Verde, Chile
Lyons, G:
Hosp Britanico, Dept Thorac Surg, Buenos Aires, DF, Argentina
Mas, L:
Natl Inst Neoplast Dis INEN, Med Oncol Dept, Lima, Peru
Mata, A:
Hosp La Catolica Goicoechea, San Jose, Costa Rica
Mathias, C:
NOB Oncoclin, Salvador, BA, Brazil
Munoz, A:
Fdn Santa Fe Bogota, Bogota, Colombia
Patane, AK:
Hosp Rehabil Resp Maria Ferrer, Buenos Aires, DF, Argentina
Oblitas, G:
Unidad Oncol Mol Peruana, Lima, Peru
Pino, L:
Fdn Santa Fe Bogota, Med Oncol Grp, Bogota, Colombia
Raez, LE:
Mem Healthcare Syst, Thorac Oncol Program, Mem Canc Inst, Pembroke Pines, FL USA
Remon, J:
HM Delfos, Ctr Integral Oncol Clara Campal Bacelona, Med Oncol Dept, Barcelona, Spain
Rojas, L:
Clin Colsanitas, Med Oncol Dept, Bogota, Colombia
Rolfo, C:
Univ Maryland, Sch Med, Marlene & Stewart Greenbaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
Ruiz-Patino, A:
Fdn Clin & Appl Canc Res, Bogota, Colombia
Samtani, S:
Clin Bradford Hill, Med Oncol Dept, Santiago, Chile
Viola, L:
Fdn Neumol Colombiana, Bogota, Colombia
Viteri, S:
Inst Oncol Dr Rosell, Ctr Med Teknon, Grp QuironSalud, Barcelona, Spain
:
Hosp Germans Trias i Pujol, Catalan Inst Oncol, Canc Biol & Precis Med Program, Barcelona, Spain
Bronze, Green Published
|